SPY415.87+4.42 1.07%
DIA340.44+2.91 0.86%
IXIC14,038.76+180.92 1.31%

BRIEF-Luye Pharma Group Granted Exclusive Rights To Commercialize New Drug In Four European Countries

· 03/16/2021 06:33
BRIEF-Luye Pharma Group Granted Exclusive Rights To Commercialize New Drug In Four European Countries

- Luye Pharma Group Ltd 2186.HK:

  • GRANTED EXCLUSIVE RIGHTS TO COMMERCIALIZE NEW DRUG RIVASTIGMINE MD IN FOUR EUROPEAN COUNTRIES TO ITALFARMACO

Source text for Eikon: nHKS9g10g0

Further company coverage: 2186.HK


((Reuters.Briefs@thomsonreuters.com;))